Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Causaly, an AI platform for drug discovery and biomedical research, raises $60M techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.
The financing, led by ICONIQ Growth, enables Causaly to accelerate innovation and drive increased adoption of its category-leading AI platform to modernize scientific research.LONDON & SAN FRANCISCO (BUSINESS WIRE) Causaly, the leading AI platform for biomedical research, closed $60m in Series B funding led by ICO.